Discount Code (0% Off) has been applied.
 
Enter a search term.

If you can't find what you were looking for, please contact us using one of the methods below so we can better serve you.

1 (800) 854-7220
answers@mcguff.com Suggest an Item

What to Expect Next

What to Expect Next

MOS Launches 503B Production with a Focus on Reliability and Expansion

Now that McGuff Outsourcing Solutions (MOS) is licensed as a California 503B outsourcing facility, our focus shifts from licensure to execution, supply stability, and expansion.

1. Manufacturing for Inventory — Not Just Launch

MOS is actively manufacturing the initial 503B products to build inventory ahead of release.

Our goal is simple: once a product becomes available, it stays available.

We are deliberately producing inventory in advance to:

  • Reduce backorders and interruptions
  • Support predictable clinic scheduling
  • Ensure continuity of care for your patients

We are building MOS to be a reliable, long-term source, not a stop-and-start supplier.

2. Initial Product Releases (California)

The following sterile 503B products are in production for California-licensed customers:

  • Alpha Lipoic Acid (ALA) Injection Solution – 40 mg/mL, 15 mL SDV
  • Reduced L-Glutathione Injection Solution – 200 mg/mL, 30 mL MDV
  • Methylcobalamin Injection Solution – 5,000 mcg/mL, 30 mL MDV
  • Procaine HCl Injection Solution – 20 mg/mL, 30 mL MDV

Product release timing will be communicated as inventory is finalized and lots are released.

3. Focus on Consistency and Reliability

MOS operates within a manufacturing environment designed for:

  • Batch-based production
  • Lot-release testing
  • Environmental and in-process controls
  • Scalable output as demand grows

This infrastructure allows us to consistently support clinics rather than sporadically.

This approach reflects MOS’s origins within a commercial pharmaceutical manufacturing organization rather than a stand-alone compounding model.

4. National Expansion Underway

With California licensure complete, MOS is actively pursuing licensure in additional states.

Customers may:

  • Request notification when MOS is licensed in their state
  • Receive updates on product availability
  • Plan future sourcing with confidence

5. Transparent Communication

As products are released and new states come online, we will provide:

  • Clear availability updates
  • Predictable ordering pathways
  • Direct access to our team for questions and planning

As we broaden our product availability and expand into additional states, our commitment remains unchanged: predictable supply, transparent communication, and unwavering support for your clinical needs. We look forward to serving you as a trusted, long-term 503B partner.

Stay Informed of Our Progress

See the states we're currently licensed in at McGuff503B.com. Be sure to sign up to receive our emails and contact us if you have additional questions.

Coronavirus (COVID-19)

Due to the Coronavirus (COVID-19) outbreak worldwide, the global demand for some Personal Protective Equipment (PPE) is exceeding current supply availability.

In addition, the manufacturing of the PPE and many other wound care/infection prevention products have been impacted by the global response to the Coronavirus. While you may see product availability reduction in the near-term, please be assured that we at McGuff Medical are continuing to work diligently to ensure an uninterrupted supply of products and alternative products to you.

Additionally, in order to ensure healthcare providers have access to the PPEs they need, the McGuff Company is temporarily limiting PPEs to healthcare providers.

As always, please feel free to reach out to our McGuff Customer Service team with any questions that you may have.

Click here for updates regarding Coronavirus Pandemic and Your Supplies and a message from our President